• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed

    2/19/21 12:25:20 PM ET
    $JAN
    Home Furnishings
    Consumer Discretionary
    Get the next $JAN alert in real time by email
    SC 13D 1 sc_13d.htm SCHEDULE 13D Schedule 13D

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    JanOne Inc

    (Name of Issuer)

    Common Shares

    (Title of Class of Securities)

    47089W104

    (CUSIP Number)

    FiveT Investment Management Ltd
    c/o DMS Corporate Services, Suite 5B201, 2nd Floor, One Nexus Way
    Camana Bay, Grand Cayman, Cayman Islands KY1-1108
    +1 345 749 2552

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

    January 29, 2021

    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    1


    CUSIP No. 47089W104

     

    13D

     

    Page 2 of 6 Pages

     

     

     

     

    1.

     

    NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    FiveT Investment Management Ltd

     

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    
    ¨
    (b)    
    ¨

     

     

    3.

     

    SEC USE ONLY
     

     

     

    4.

     

    SOURCE OF FUNDS (see instructions)
     
    WC

     

     

    5.

     

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨

     

     

    6.

     

    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands

     

     

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

     

    7.

     

    SOLE VOTING POWER
     
    00,000

     

    8.

     

    SHARED VOTING POWER
     
    00,000

     

    9.

     

    SOLE DISPOSITIVE POWER
     
    00,000

     

    10.

     

    SHARED DISPOSITIVE POWER
     
    00,000

     

    11.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    00,000

     

     

    12.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    (see instructions)    
    ¨

     

     

    13.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    0.00%

     

     

    14.

     

    TYPE OF REPORTING PERSON (see instructions)

    CO

     

     

     

    2


    CUSIP No. 47089W104

     

    13D

     

    Page 3 of 6 Pages

     

     

     

     

    1.

     

    NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    FiveT Capital AG

     

     

    2.

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    
    ¨
    (b)    
    ¨

     

     

    3.

     

    SEC USE ONLY
     

     

     

    4.

     

    SOURCE OF FUNDS (see instructions)
     
    OO

     

     

    5.

     

    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     ¨

     

     

    6.

     

    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Switzerland

     

     

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

     

    7.

     

    SOLE VOTING POWER
     
    00,000

     

    8.

     

    SHARED VOTING POWER
     
    00,000

     

    9.

     

    SOLE DISPOSITIVE POWER
     
    00,000

     

    10.

     

    SHARED DISPOSITIVE POWER
     
    00,000

     

    11.

     

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    00,000

     

     

    12.

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    (see instructions)    
    ¨

     

     

    13.

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    0.00%

     

     

    14.

     

    TYPE OF REPORTING PERSON (see instructions)

    IA

     

     

     

    3


    CUSIP No. 47089W104

     

    13D

     

    Page 4 of 6 Pages

     

     

     

     

    Item 1.  Security and Issuer.

    Cusip:

    47089W104

    Issuer:

    JanOne Inc
    325 East Warm Springs Road
    Suite 102
    Las Vegas, NV 89119

     

    Item 2.  Identity and Background.

    Name of person filing:

    FiveT Investment Management Ltd
    FiveT Capital AG

    Registered address or principle place of business:

    FiveT Investment Management Ltd
    c/o DMS Corporate Services, Suite 5B201, 2nd Floor, One Nexus Way,
    Camana Bay, Grand Cayman, Cayman Islands KY1-1108

    FiveT Capital AG
    Allmendstrasse 140, 8041 Zurich, ZH, Switzerland

     

    Item 5.  Interest in Securities of the Issuer.

    As of the date of this Schedule 13D, the Reporting Persons acquired an aggregate of 190,476 shares of Common Stock, consisting of 190,476 shares held by the FiveT Investment Management Ltd (the “Shares”).  The Shares represent 7.93% of the Common Stock outstanding.  On the same date, the Reporting Persons sold an aggregate of 190,476 Shares.  As of the date of this Schedule 13D, the Reporting Persons beneficially own an aggregate of 0 shares of Common Stock. The Shares represent 0.00% of the Common Stock outstanding.

     

    Item 7.  Material to Be Filed as Exhibits.

    Schedule I

     

    4


    CUSIP No. 47089W104

     

    13D

     

    Page 5 of 6 Pages

     

     

     

     

     

     

    Schedule I

     

    This Schedule sets forth information with respect to each purchase and sale of Shares which was effectuated by a Reporting Person in the last 60 days since the date of the event which requires filing of this Statement. 

    Unless otherwise indicated, all transactions were effectuated in the open market through a broker.

     

    Trade Date

    Shares Purchased (Sold)

    Price Per Share ($)

    01/29/2021

    190,476

    10.50

    01/29/2021

    (190,476)

    9.755

     

     

     

     

    5


    CUSIP No. 47089W104

     

    13D

     

    Page 6 of 6 Pages

     

     

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    FIVEMORE SPECIAL SITUATIONS FUND LTD

    /s/ Wieland Kreuder

    Authorized Person

    January 29, 2021

     

    Get the next $JAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JAN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ALT5 Sigma Corporation Partners With Hashtag Influencer to Enable Cryptocurrency Payment Processing for Influencer Marketing

      LAS VEGAS, NV / ACCESSWIRE / January 15, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a prominent innovator in the cryptocurrency sector, is pleased to announce a partnership with Hashtag Influencer, an advanced AI-powered SocialFi platform. This collaboration aims to enhance the influencer marketing landscape by enabling influencers in the gig economy to seamlessly and compliantly accept cryptocurrency payments for advertising deals with brands through social media platforms such as Instagram, Facebook, YouTube, and LinkedIn."While much attention has been given to the adoption of blockchain by traditional institutions, collaborating with innovators such as Hashtag Influencer-a forthcoming A

      1/15/25 7:00:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week

      Finalist to present at RESI JPM IPC and attend the Nasdaq Opening Bell Ceremony on January 13 LAS VEGAS, NV / ACCESSWIRE / January 10, 2025 / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events during the 43rd Annual J.P. Morgan Healthcare Conference Week, to be held on January 13-16, 2025, in San Francisco, California. Alyea is developing innovative, actionable solutions intended to help end the opioid crisis with its lead asset ("JAN123"), a novel formulation of Low Dose Naltrexone ("LDN"), preparing for its pivotal Phase III study. Having already been granted Orphan Drug designa

      1/10/25 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • ALT5 Sigma to Exhibit at iFX EXPO Dubai January 14-16, 2025

      LAS VEGAS, NV / ACCESSWIRE / January 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced its participation in the upcoming iFX EXPO Dubai.ALT5 will be exhibiting through the three days of the show at the Dubai World Trade Centre, providing product demonstrations, solutions and general information to many of the 7,000+ attendees starting January 14th in booth #26.iFX EXPO Dubai 2025 is the ultimate meeting place for brokers, affiliates, traders, investors, and tech- and service-providers who are looking to succeed in the MENA

      1/9/25 11:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Financials

    Live finance-specific insights

    See more

    $JAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

      -The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisi

      7/10/24 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

      The acquisition of Soin provides JanOne with its second, late stage clinical stage asset LAS VEGAS, Jan. 10, 2023 /PRNewswire/ -- JanOne Inc. ("JanOne") (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that it has completed the acquisition of Soin Therapeutics, LLC and its product, a patent-pending, novel formulation of low-dose naltrexone. This all stock transaction has a value of $13M, with up to an additional $17M depending on revenues generated by the product, for a total value of up to $30M. The transaction includes restrictions on the maximum number of shares of preferred stock and common stock that can be i

      1/10/23 8:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder

      LAS VEGAS, Dec. 7, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties - in an effort to further reduce the drug addiction epidemic - today announced an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO).  The agreement with LSU Health Shreveport, along with other intellectual property relating to TSPO's role in treating meth use disorder (MUD), provides JanOne Inc. with an opportunity to identify new drugs to enhance TSPO activity, and by doing so, reducing craving for meth. This new strategy for treating MUD w

      12/7/21 9:00:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      8/24/23 4:30:55 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G filed by JanOne Inc.

      SC 13G - JanOne Inc. (0000862861) (Subject)

      3/27/23 9:00:21 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

      SC 13G/A - JanOne Inc. (0000862861) (Subject)

      2/11/22 6:07:45 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Isaac Antonios was granted 125,787 shares, increasing direct ownership by 137% to 217,787 units

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:30:05 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A was granted 78,617 shares

      4 - JanOne Inc. (0000862861) (Issuer)

      1/9/23 4:20:58 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 4: Johnson Virland A sold $220,651 worth of Common Shares (32,933 units at $6.70), decreasing direct ownership by 100% to 0 units

      4 - JanOne Inc. (0000862861) (Issuer)

      5/26/21 4:02:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    SEC Filings

    See more
    • JanOne Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ALT5 Sigma Corp (0000862861) (Filer)

      7/17/24 2:55:12 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:22:48 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • SEC Form 424B5 filed by JanOne Inc.

      424B5 - JanOne Inc. (0000862861) (Filer)

      6/21/24 5:20:23 PM ET
      $JAN
      Home Furnishings
      Consumer Discretionary

    $JAN
    Leadership Updates

    Live Leadership Updates

    See more
    • ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors

      LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors."We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team,"

      11/6/24 8:30:00 AM ET
      $ALTS
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma

      LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).

      6/26/24 7:30:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary
    • JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

      LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world's leaders on the role of stress in drug addiction.  Tony Isaac, President and Chief Executive Officer of JanOne, commented, "JanOne's mission is to develop non-addictive medications to treat diseases that cause severe pain, thereby m

      6/15/21 10:15:00 AM ET
      $JAN
      Home Furnishings
      Consumer Discretionary